THE ROLE OF POLYUNSATURATED FATTY ACIDS IN THE PREVENTION AND TREATMENT OF ATOPIC DERMATITIS

DOI: https://doi.org/10.29296/25877305-2024-06-15
Issue: 
6
Year: 
2024

Professor V. Revyakina, MD; N. Tarmaeva
Federal Research Centre of Nutrition, Biotechnology and Food Safety, Moscow

Atopic dermatitis (AD) is one of the most common chronic skin diseases that require an integrated approach to treatment and prevention. The role of nutrition in the development and treatment of this disease is attracting more and more attention from specialists. The purpose of this article was to determine the role of polyunsaturated fatty acids (PUFAs) in the prevention and treatment of AD based on an analysis of modern literature collected by searching the PubMed, Scopus and eLibrary databases for the period 2000-2024, as well as scientific journals in the field of dermatology and allergology and nutrition. In recent decades, significant changes have been observed in the structure of human nutrition. Diverse dietary components shape dietary habits and preferences, which can influence the likelihood of developing various chronic diseases, including AD. With the increasing prevalence of allergic diseases, there is an urgent need for a better understanding of the various modifying factors that cause such conditions. According to modern research, in the pathogenesis of AD development, special attention is paid to the ratio of ω-6 and ω-3 PUFAs in diets, which play an important role in improving skin condition due to their anti-inflammatory effect, helping to strengthen the skin barrier and reduce the symptoms of the disease. The use of ω-3 and ω-6 PUFAs for the most common skin diseases has been studied in numerous studies, but their results and conclusions have been largely contradictory and inconclusive. Thus, based on the review, we can conclude about the importance of including PUFAs in the diet of patients with AD to improve the effectiveness of treatment and prevention of this disease. Further research in this area will help in the development of more effective methods of controlling AD through nutritional correction.
Keywords: 
polyunsaturated fatty acids
ω-3
ω-6
atopic dermatitis
nutrition

References: 
  1. Langan S.M., Irvine A.D., Weidinger S. Atopic dermatitis. Lancet. 2020; 396 (10247): 345–60. DOI: 10.1016/S0140-6736(20)31286-1
  2. Celebi Sözener Z., Cevhertas L., Nadeau K. et al. Environmental factors in epithelial barrier dysfunction. J Allergy Clin Immunol. 2020; 145 (6): 1517–28. DOI: 10.1016/j.jaci.2020.04.024
  3. Loxham M., Davies D.E. Phenotypic and genetic aspects of epithelial barrier function in asthmatic patients. J Allergy Clin Immunol. 2017; 139 (6): 1736–51. DOI: 10.1016/j.jaci.2017.04.005
  4. Глухова Е.А., Мухортых В.А., Тамразова О.Б., и др. Предикторы тяжелого течения атопического дерматита. Вопросы питания. 2022; 91 (1): 76–85 [Gluhova E.A., Muhortyh V.A., Tamrazova O.B. et al. Predictors of severe atopic dermatitis. Problems of nutrition. 2022; 91 (1): 76–85 (in Russ.)]. DOI: 10.33029/0042-8833-2022-91-1-76-85
  5. Egawa G., Kabashima K. Barrier dysfunction in the skin allergy. Allergol Int. 2018; 67 (1): 3–11. DOI: 10.1016/j.alit.2017.10.002
  6. Menon G.K., Lee S.E., Lee S.H. An overview of epidermal lamellar bodies: Novel roles in biological adaptations and secondary barriers. J Dermatol Sci. 2018; 92 (1): 10–7. DOI: 10.1016/j.jdermsci.2018.03.005
  7. Holt P.G., Jones C.A. The development of the immune system during pregnancy and early life. Allergy. 2000; 55 (8): 688–97. DOI: 10.1034/j.1398-9995.2000.00118.x
  8. Ревякина В.А., Ларькова И.А., Кувшинова Е.Д. и др. Новые пути решения старой проблемы: особенности течения и лечения атопического дерматита в сочетании с бронхиальной астмой у детей. Вопросы практической педиатрии. 2019; 14 (2): 61–7 [Revjakina V.A., Lar'kova I.A., Kuvshinova E.D., et al. New solutions to the old problem: features of the course and treatment of atopic dermatitis in combination with bronchial asthma in children. Сlinical practice in pediatrics. 2019; 14 (2): 61–7 (in Russ.)]. DOI: 10.20953/1817-7646-2019-2-61-67
  9. Calder P.C. Long-chain fatty acids and inflammation. Proc Nutr Soc. 2012; 71 (2): 284–9. DOI: 10.1017/S0029665112000067
  10. Flohr C., Mann J. New Insights into the Epidemiology of Childhood Atopic Dermatitis. Allergy. 2014; 69: 3–16. DOI: 10.1111/all.12270
  11. Horrobin D.F. Essential fatty acid metabolism and its modification in atopic eczema. Am J Clin Nutr. 2000; 71 (1 Suppl): 367S-72S. DOI: 10.1093/ajcn/71.1.367s
  12. Ших Е.В., Махова А.А. Длинноцепочечные полиненасыщенные жирные кислоты семейства ω-3 в профилактике заболеваний у взрослых и детей: взгляд клинического фармаколога. Вопросы питания. 2019; 88 (2): 91–100 [Shih E.V., Mahova A.A. Long-chain polyunsaturated fatty acids of the ω-3 family in the prevention of diseases in adults and children: a clinical pharmacologist's view. Problems of nutrition. 2019; 88 (2): 91–100 (in Russ.)]. DOI: 10.24411/0042-8833-2019-10022
  13. Best K.P., Gold M., Kennedy D. et al. Omega-3 long-chain PUFA intake during pregnancy and allergic disease outcomes in the offspring: a systematic review and meta-analysis of observational studies and randomized controlled trials. Am J Clin Nutr. 2016; 103: 128–43. DOI: 10.3945/ajcn.115.111104
  14. Calder P.C., Kremmyda L.S., Vlachava M. et al. Is there a role for fatty acids in early life programming of the immune system? Proc Nutr Soc. 2010; 69: 373–80. DOI: 10.1017/S0029665110001552
  15. D'Auria E., Miraglia Del Giudice M., Barberi S. et al. Omega-3 fatty acids and asthma in children. Allergy Asthma Proc. 2014; 35: 233–40. DOI: 10.2500/aap.2014.35.3736
  16. Furuhjelm C., Warstedt K., Fagerås M. et al. Allergic disease in infants up to 2 years of age in relation to plasma omega-3 fatty acids and maternal fish oil supplementation in pregnancy and lactation. Pediatr Allergy Immunol. 2011; 22: 505–14. DOI: 10.1111/j.1399-3038.2010.01096.x
  17. Best K.P., Sullivan T.R., Palmer D.J. et al. Prenatal omega-3 LCPUFA and symptoms of allergic disease and sensitization throughout early childhood – a longitudinal analysis of long-term follow-up of a randomized controlled trial. World Allergy Organ J. 2018; 11 (1): 10. DOI: 10.1186/s40413-018-0190-7
  18. Gunaratne A.W., Makrides M., Collins C.T. Maternal prenatal and/or postnatal n-3 long chain polyunsaturated fatty acids (LCPUFA) supplementation for preventing allergies in early childhood. Cochrane Database Syst Rev. 2015; 22: CD010085. DOI: 10.1002/14651858.CD010085.pub2